Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
Year: 1994
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: Fox Chase Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: macrophage colony-stimulating factor, interferon-gamma, combination therapy, monocytosis, thrombocytopenia, drug toxicity, Fc gamma receptor III, CD16, monocyte activation, CD14, maximum tolerated dose, hepatotoxicity, chronic obstructive pulmonary disease, mononuclear phagocytes, continuous infusion, immunomodulation
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2125237590
